Likewise, the administration of tetrandrine proceeded intravenously in a rat model of Alzheimer's disease showed improvement in memorial and learning disability along with the decrease in the expression of TNF-α and IL-1β through the inhibition of the NF-κB pathway [104]. Here, NFKB1 is linked to early-onset autosomal dominant Alzheimer disease.